Cibc World Markets Corp Acquires New Holdings in Balchem Co. (NASDAQ:BCPC)

Cibc World Markets Corp acquired a new stake in shares of Balchem Co. (NASDAQ:BCPC) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 3,025 shares of the basic materials company’s stock, valued at approximately $493,000.

Other institutional investors have also recently bought and sold shares of the company. Natixis Advisors LLC lifted its stake in Balchem by 2.1% in the third quarter. Natixis Advisors LLC now owns 21,797 shares of the basic materials company’s stock valued at $3,836,000 after buying an additional 453 shares in the last quarter. Pathstone Holdings LLC lifted its stake in Balchem by 6.5% in the third quarter. Pathstone Holdings LLC now owns 10,361 shares of the basic materials company’s stock valued at $1,824,000 after buying an additional 632 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. bought a new position in Balchem in the third quarter valued at approximately $1,153,000. Intech Investment Management LLC lifted its stake in Balchem by 55.6% in the third quarter. Intech Investment Management LLC now owns 8,611 shares of the basic materials company’s stock valued at $1,516,000 after buying an additional 3,077 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its stake in Balchem by 2.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 361,970 shares of the basic materials company’s stock valued at $63,707,000 after buying an additional 7,562 shares in the last quarter. Institutional investors and hedge funds own 87.91% of the company’s stock.

Balchem Stock Performance

Shares of BCPC stock opened at $161.17 on Friday. The company’s fifty day simple moving average is $164.71 and its 200-day simple moving average is $169.42. The company has a quick ratio of 1.16, a current ratio of 1.99 and a debt-to-equity ratio of 0.19. The firm has a market cap of $5.24 billion, a PE ratio of 41.01, a P/E/G ratio of 4.41 and a beta of 0.63. Balchem Co. has a 12 month low of $137.69 and a 12 month high of $186.03.

Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing analysts’ consensus estimates of $1.11 by ($0.08). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The business had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. Equities research analysts expect that Balchem Co. will post 4.64 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on the stock. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research note on Tuesday, February 25th. HC Wainwright reissued a “buy” rating and issued a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. Finally, Sidoti raised shares of Balchem to a “hold” rating in a research report on Tuesday, February 25th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.